L-Mesitran: Medical Grade Honey for Advanced Wound Care

L-Mesitran: The Clinician's Guide to Medical Grade Honey Wound Care

L-Mesitran is a range of licensed medical grade honey dressings used to manage acute and chronic wounds, and it works differently from any honey found on a supermarket shelf. For wound care nurses, podiatrists, and surgeons across South Africa, the question is rarely whether honey has a place in modern wound care. It does. The real question is which format suits a given wound bed, what the evidence actually shows, and how to source the full range reliably.

This guide answers those questions in one place. It covers how medical grade honey works, the seven L-Mesitran formats available locally, a wound bed selection matrix, the clinical evidence behind the range, and honest limits every clinician should know before applying it.

What Is L-Mesitran and How Does Medical Grade Honey Work?

L-Mesitran is a CE-marked medical device built around medical grade honey, not food-grade honey. That distinction matters clinically and legally.

Medical grade honey is produced under controlled conditions and sterilised by gamma irradiation. This step removes the risk of Clostridium botulinum spores and other contaminants that can be present in raw honey, while leaving the honey's antimicrobial properties intact. Which means a clinician can apply it directly to an open wound with confidence.

Supermarket honey is a food product. It is not sterilised, its composition is not standardised, and it carries no regulatory approval for wound use. Applying it to a wound risks introducing bacterial spores into compromised tissue.

L-Mesitran also enriches its honey base with supportive ingredients such as vitamins C and E, zinc oxide, and medical-grade lanolin, depending on the format. These support the wound environment rather than acting as drugs.

Explore the full advanced wound care range to see where honey-based dressings fit alongside other modalities.

The Mechanism of Action: Antimicrobial, Debriding, and Anti-Inflammatory Effects

L-Mesitran acts through several physical mechanisms at once, which is why bacteria do not develop resistance to it the way they do to antibiotics.

• Osmotic effect: the high sugar concentration draws fluid out of bacterial cells and out of the wound, supporting autolytic debridement of slough and necrotic tissue.
• Low pH: honey acidifies the wound surface, creating conditions that inhibit bacterial growth and support healing.
• Hydrogen peroxide generation: glucose oxidase in the honey releases hydrogen peroxide slowly and at low, tissue-safe levels, providing sustained antimicrobial action.

Together these effects reduce bioburden, loosen devitalised tissue, and calm the inflammatory phase. The result is a moist wound environment that supports granulation.

The L-Mesitran Product Range: Choosing the Right Format for the Wound Bed

The L-Mesitran range spans seven formats, each with a different honey concentration, carrier, and exudate profile. Matching the format to the wound is what separates a good outcome from a stalled one.

Scroll the table sideways to see all columns.

Browse the antimicrobial wound dressings category for the complete specification of each format.

L-Mesitran Soft: The Versatile Honey Wound Gel for Moist Wound Healing

L-Mesitran Soft is the most widely used format and the usual starting point for clinicians new to the range. It contains 40% medical grade honey in a supplemented hydrogel, which means it delivers antimicrobial action while adding moisture to drier beds.

Soft suits superficial and cavity wounds, mixed red and yellow wound beds, and fragile or sensitive skin. It spreads easily and rinses out cleanly at dressing changes. See the L-Mesitran Soft wound gel for full details.

L-Mesitran Ointment: For Dry, Superficial, and Peri-Wound Skin

L-Mesitran Ointment carries a higher honey concentration at 48% in a lanolin-based ointment. It is designed for dry and lightly exuding wounds, superficial burns, and the protection of vulnerable peri-wound skin.

Because it is occlusive, it holds moisture against a dry bed without macerating surrounding tissue. Review the L-Mesitran Ointment product page for indications and application notes.

Clinical Indications: Which Wounds Respond Best to L-Mesitran

L-Mesitran is indicated across a wide spectrum of acute and chronic wounds, but it performs best on colonised, sloughy, or stalled wounds where bioburden is holding back healing.

Common indications include:

• Chronic wounds: venous leg ulcers, arterial ulcers, pressure injuries, and diabetic foot ulcers.
• Acute wounds: surgical wounds, traumatic wounds, skin tears, and abrasions.
• Burns: superficial and partial-thickness burns.
• Colonised and malodorous wounds: where honey's antimicrobial and deodorising action helps.

The format follows the wound. A dry, superficial pressure injury calls for Ointment or Hydro, while a moderately exuding sloughy ulcer calls for Soft or Foam. Use the matrix below to match the wound bed and exudate level to the right format. This guidance is for clinicians assessing wounds: it does not replace individual patient assessment.

Scroll the table sideways to see all columns.

For a foam option in exuding wounds, see the L-Mesitran Foam dressing, and for a non-adherent contact layer, the L-Mesitran Tulle.

Application Technique and Dressing Change Protocol

Correct application decides whether L-Mesitran delivers its full effect. The technique is simple, but a few steps are easy to get wrong.

1. Cleanse the wound. Irrigate with saline or purified water and gently remove loose debris.
2. Apply the honey generously. For Soft and Ointment, apply a layer roughly 3 mm to 5 mm thick across the wound bed. A thin smear is not enough to sustain the osmotic gradient.
3. Fill cavities loosely. Pack Soft into cavities without tension: over-packing raises pressure on the wound bed.
4. Cover with a secondary dressing. Match absorbency to exudate: a low-adherent pad for light exudate, a foam or absorbent pad for heavier exudate.
5. Secure and date the dressing.

Dressing change frequency depends on exudate and honey depletion. Honey is diluted by wound fluid over time, so heavily exuding wounds may need daily changes, while dry, low-exudate wounds can hold a dressing for up to seven days.

A practical tip from clinical use: if the secondary dressing sticks or the patient reports tightness, moisten it with purified water before removal. This reduces trauma and discomfort.

For bordered convenience, the L-Mesitran Border combines the honey layer and fixation in one dressing.

Integrating L-Mesitran Into Your Wound Care Protocol

L-Mesitran fits neatly into a structured wound care protocol, and the strongest evidence supports its use as an antimicrobial and debriding option.

A University of Ghent laboratory study, published in the journal Antibiotics (MDPI), tested medical grade honey products against wound biofilms. L-Mesitran Soft demonstrated stronger anti-biofilm activity than several comparator medical grade honey products in that in-vitro model. That is what the study found: it is not a claim that the product is superior in every clinical setting.

A separate clinical evaluation of L-Mesitran Foam, indexed on PubMed Central (PMC), reported positive outcomes in exuding wounds, supporting its role where absorption and antimicrobial cover are both needed.

When adding L-Mesitran to a protocol, clinicians typically position it at the antimicrobial or debridement step of the wound-bed-preparation pathway, alongside sharp or autolytic debridement. It pairs with compression in venous ulcer management and with offloading in diabetic foot care.

For moisture-retentive granulating beds, the L-Mesitran Hydro supports the healing phase. Read more about medical grade honey in wound care for the wider clinical context.

Safety, Contraindications, and Patient Considerations

L-Mesitran has a strong safety record, but honest limits matter. Clinicians should know what to expect and where the product is not appropriate.

Transient pain is the most common consideration. The osmotic action of the sugars and the drop in wound pH can cause a stinging or drawing sensation on application, particularly on sensitive or neuropathic-adjacent tissue. This usually subsides within an hour. Moistening the secondary dressing with purified water reduces it, and persistent pain warrants review.

Contraindications and cautions:

• Known hypersensitivity to any ingredient, including honey, lanolin, or bee-derived components.
• Caution in patients with a diagnosed allergy to bee products.
• An initial increase in exudate is normal as the osmotic effect draws fluid: select an adequately absorbent secondary dressing rather than abandoning the product.

L-Mesitran is safe to use across most patient groups when applied by a competent clinician. It does not sting the way an antiseptic solution does, and diabetic patients can use it, as the sugar is not absorbed systemically through intact wound management.

When in doubt, patch-test or trial on a small area first. That five-minute step can prevent an avoidable adverse reaction.

This information is intended as a general guide. Always consult a registered healthcare professional for diagnosis and treatment of any medical condition.

L-Mesitran in South Africa: SAHPRA Status, Distribution, and Ordering

Dynamed is the exclusive South African distributor of L-Mesitran. That means one accountable source of supply for the entire range, not a partial listing.

For procurement officers, this section covers the essentials.

• Regulatory standing: L-Mesitran is supplied in line with South African medical device requirements and SAHPRA regulations, with Dynamed handling regulatory and documentation matters as the responsible distributor.
• Full-range availability: all seven formats, from Soft to Active, are held in stock rather than sourced ad hoc.
• Nationwide delivery: dispatch runs from warehouses in Durban and Johannesburg, reaching public and private facilities across the country.
• Clinical training and protocol support: the Dynamed clinical team provides in-service training, format selection guidance, and protocol integration support. A reseller can list a product: only the distributor can support its correct use.
• Bulk and tender supply: structured pricing for hospitals, groups, and government tenders, with single-source-of-supply assurance.

No prices are published here because facility, volume, and tender terms differ. For hospital-scale needs, see the full range of hospital wound care supplies.